Goldman Sachs upgraded its rating on shares of Quest Diagnostics Inc. (DGX) Thursday morning to "Buy" from "Neutral."
Quest Diagnostics gapped open higher Thursday and has continued to rise in early trade. Shares are now up 2.03 at $59.33. The stock has climbed to a 2 1/2 month high and has re-crossed its 200-day moving average.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.